ID   Ca 18/3
AC   CVCL_RP29
SY   CA 18/3; Ca18/3
DR   Wikidata; Q54808282
RX   PubMed=11439348;
CC   Derived from site: In situ; Thyroid gland; UBERON=UBERON_0002046.
DI   NCIt; C4035; Thyroid gland papillary carcinoma
DI   ORDO; Orphanet_146; Differentiated thyroid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 29-06-23; Version: 6
//
RX   PubMed=11439348; DOI=10.1038/sj.onc.1204531;
RA   Frasca, Francesco
RA   Vigneri, Paolo
RA   Vella, Veronica
RA   Vigneri, Riccardo
RA   Wang, Jean Yin-Jen
RT   "Tyrosine kinase inhibitor STI571 enhances thyroid cancer cell motile
RT   response to hepatocyte growth factor.";
RL   Oncogene 20:3845-3856(2001).
//